Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. QCOM
2. FDX
3. CBRS
4. USO
5. MU
6. SPY
7. KBH
8. HON
9. HTZ
10. GOOGL

Go back to Aravive Reports Positive Data Supporting Relationship Between AVB-500 Levels, Anti-Tumor Activity and Progression Free Survival in Women with Ovarian Cancer

Aravive Inc. (ARAV) Halted on LUDP

November 20, 2019 9:46 AM EST

Aravive Inc. (NASDAQ: ARAV) Halted on LUDP

... More

Aravive Inc. (ARAV) Extends Gain, Up 250%

November 20, 2019 7:43 AM EST

Aravive Inc. (NASDAQ: ARAV) Extends Gain, Up 250%

... More

Aravive Inc. (ARAV) Climbs 80% After Positive Data from Ongoing Trial of AVB-500 in Ovarian Cancer

November 20, 2019 7:21 AM EST

Aravive Inc. (NASDAQ: ARAV) Climbs 80% After Positive Data from Ongoing Trial of AVB-500 in Ovarian Cancer

... More